Premedication with flunitrazepam in gastro-intestinal endoscopy.
Administration of 2 mg flunitrazepam (Rohypnol; Roche) to patients before gastro-intestinal endoscopy caused significantly less anxiety and achieved significantly greater sedation than diazepam (Vallium; Roche). No differences were found between any of the trial groups with respect to ease of intubation, tolerance of the procedure, gastric peristalsis, and the state of the pylorus. Memory of the procedure was significantly less vivid in the groups who received 2 mg flunitrazepam, than in the other groups. The patients who received 2 mg flunitrazepam showed a significantly greater willingness to undergo a repeat procedure, both when asked immediately after the procedure, and when asked on the next visit. Pulse rate increased in all groups during the procedure. No change in respiratory rate or in systolic and diastolic blood pressure occurred in any group.
D014151:Anti-Anxiety Agents; D003975:Diazepam; D004386:Duodenum; D004724:Endoscopy; D005445:Flunitrazepam; D005773:Gastroscopy; D006801:Humans; D011292:Premedication; D011413:Propantheline
D014151:Anti-Anxiety Agents; D011413:Propantheline; D005445:Flunitrazepam; D003975:Diazepam